SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-153792
Filing Date
2020-05-28
Accepted
2020-05-28 08:08:33
Documents
5
Period of Report
2020-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d933839d8k.htm 8-K 20451
2 EX-10.1 d933839dex101.htm EX-10.1 40774
3 EX-10.2 d933839dex102.htm EX-10.2 39023
4 EX-99.1 d933839dex991.htm EX-99.1 11180
5 GRAPHIC g933839g0528024757607.jpg GRAPHIC 4525
  Complete submission text file 0001193125-20-153792.txt   118976
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 20917236
SIC: 2836 Biological Products, (No Diagnostic Substances)